Hypersensitivity to the active substance or to any of the excipients listed in Description.
As IXAZOMIB (NINLARO) is administered in combination with lenalidomide and dexamethasone, refer to the SmPC for these medicinal products for additional contraindications.
Other Services
Country
Account